ArticleTropical medicine and infectious disease2025

Risk of Latent Tuberculosis Infection Reactivation in Patients Treated with Tumor Necrosis Factor Antagonists: A Five-Year Retrospective Study.

Işıl Deniz Alıravcı et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.